Kamada Plunges on for Hereditary Emphysema Lung Treatment Results

Kamada Ltd. (Nasdaq: KMDA); TASE: KMDA) today confirmed the results of its initial trial published three and a half months ago. At that time, the company reported disappointing results in its Phase II/III More...